List view / Grid view

Regs & Legs


Kymab secures $100 million Series C funding

1 December 2016 | By Niamh Louise Marriott, Digital Editor

The funds will enable Kymab to advance its proprietary pipeline of first-in-class therapeutic human monoclonal antibodies, with clinical development in 2017...

Promising antibiotic programme gets European boost

21 November 2016 | By Niamh Louise Marriott, Digital Content Producer

Researchers at the University of Oxford have been working with two major EU-funded projects to deliver a novel antibiotic programme for clinical development...

Send this to a friend